Prolonged molecular and clinical remission after treatment of a patient with follicular lymphoma with rituximab.

Buckstein, R J; Rimrie, K; Pennell, N; Spaner, D; Hewitt, K; Berinstein, N L

Buckstein, R J; Rimrie, K; Pennell, N; Spaner, D; Hewitt, K; Berinstein, N L.

Affiliation

Buckstein RJ; Advanced Therapeutics Program, Toronto Sunnybrook & Women's College Health Sciences Centre; Toronto, Ontario, Canada. rena.buckstein@tsrcc.on.ca

Leuk Lymphoma ; 41(3-4): 451-5, 2001 Apr.

Article in En | MEDLINE | ID: mdl-11378562

Subject(s)

Antibodies, Monoclonal/administration & dosage; Antineoplastic Agents/administration & dosage; Lymphoma, Follicular/drug therapy; Adult; Antibodies, Monoclonal, Murine-Derived; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; Follow-Up Studies; Humans; Male; Polymerase Chain Reaction; Recurrence; Remission Induction; Rituximab; Translocation, Genetic/genetics

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Follicular / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies Limits: Adult / Humans / Male Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2001 Type: Article Affiliation country: Canada

Search on Google

XML

PubMed Links